跳至主要内容
临床试验/NCT05973604
NCT05973604招募中不适用

Prevalence of Primary Aldosteronism in Patients With Atrial Fibrillation (ERETRIA Trial)

Aristotle University Of Thessaloniki1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2021年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
1
主要终点
Prevalence of primary aldosteronism in patients with atrial fibrillation

研究概览

简要总结

This is an observational prospective cross-sectional study, investigating the prevalence of primary aldosteronism in patients with atrial fibrillation.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Established diagnosis of atrial fibrillation with a standard surface ECG tracing of at least 30 seconds (either paroxysmal or persistent or permanent).

排除标准

  • Diagnosis of primary aldosteronism
  • Diagnosis of heart failure, treated with mineralocorticoid receptor antagonists
  • Inability to be subjected to any confirmatory tests for primary aldosteronism
  • Acute vascular event (acute coronary syndrome, stroke, acute peripheral vascular event) within last 6 months
  • Renal replacement therapy
  • Incompetence of unwillingness to provide written informed consent

结局指标

主要结局

Prevalence of primary aldosteronism in patients with atrial fibrillation

时间窗: Baseline

Percentage of patients with positive screening and confirmatory test for primary aldosteronism

次要结局

  • Association of echocardiographic indices with presence of primary aldosteronism in patients with atrial fibrillation.(Baseline)
  • Association of marker of arterial stiffness with presence of primary aldosteronism in patients with atrial fibrillation(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Maria Toumpourleka

Principal Investigator

Aristotle University Of Thessaloniki

研究点 (1)

Loading locations...

相似试验